Recommendations on antithrombotic treatment during the COVID-19 pandemic. Position statement of the Working Group on Cardiovascular Thrombosis of the Spanish Society of Cardiology | Revista Española de Cardiología
Bridging the Gap: How to Transition from the NOACs to Warfarin - PDF Free Download
Antithrombotic Management of Venous Thromboembolism: JACC Focus Seminar - ScienceDirect
Cureus | Clinical Outcomes and Costs of Rivaroxaban for Thromboprophylaxis in Acutely Ill Medical Inpatients: A Cross-Sectional Study
Transition of Anticoagulants 2016
Apixaban versus enoxaparin for thromboprophylaxis after knee replacement (ADVANCE-2): a randomised double-blind trial - The Lancet
Direct Oral Anticoagulant Use: A Practical Guide to Common Clinical Challenges | Journal of the American Heart Association
Anticoagulants | Health Navigator NZ
How to switch from rivaroxaban to LMWH? | Download Scientific Diagram
Time for a change? Switching anticoagulants in patients with AF or VTE | Thrombosis Adviser
RBCP - Cost comparison between enoxaparin and new oral anticoagulants dabigatran and rivaroxaban in venous thromboembolism prophylaxis
Care Transitions in Anticoagulation Management for Patients With Atrial Fibrillation: An Emphasis on Safety | Ochsner Journal
Guideline for the Prescribing of Novel Oral Anticoagulants (NOACs): Dabigatran (Pradaxa ), Rivaroxaban (Xarelto ), Apixaban (Eliquis ) - PDF Free Download
Rivaroxaban: a fully-subsidised oral anticoagulant
Dose of XARELTO for Switching From Another Anticoagulant During Initial DVT or PE Treatment
Aspirin and an oral anticoagulant – can they be used together? - NPS MedicineWise
Direct Oral Anticoagulant Use: A Practical Guide to Common Clinical Challenges | Journal of the American Heart Association
Oral anticoagulants in the management of venous thromboembolism | Nature Reviews Cardiology
Oral rivaroxaban versus enoxaparin with vitamin K antagonist for the treatment of symptomatic venous thromboembolism in patients with cancer (EINSTEIN-DVT and EINSTEIN-PE): a pooled subgroup analysis of two randomised controlled trials -